Earnings History Data for Galapagos NV (GLPG) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Galapagos NV

Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
22-02-2024 AH GLPG Galapagos NV 2,550 N/A -2.23 -1.99 Galapagos GAAP EPS of €3.21, revenue of €239.7M
[2/22/2024 4:02 PM]		 36.24 -3.27 
(-8.26%)		 37.44 -2.07 
(-5.24%)		 31.86 - 45.21 516,988 100,000 2,769
03-11-2023 AH GLPG Galapagos NV 2,200 0.42 -1.03 0.33 Galapagos GAAP EPS of €0.82, revenue of €448.85M
[11/2/2023 4:59 PM]		 37.05 2.52 
(7.30%)		 36.83 2.30 
(6.66%)		 31.86 - 48.07 237,330 220,000 15,112
04-05-2023 AH 4:00 PM ET
(May 4)		 GLPG Galapagos NV 2,700 0.43 -1.83 -0.22 Galapagos GAAP EPS of €0.40, revenue of €178.9M
[5/4/2023 4:04 PM]		 42.90 2.40 
(5.93%)		 41.54 1.04 
(2.57%)		 36.17 - 61.17 756,939 290,000 2,256
03-11-2022 AH 4:00 PM ET
(Nov 3)		 GLPG Galapagos NV 3,020 0.33 -1.17 -1.17 Galapagos GAAP EPS of -€0.16, revenue of €410.2M
[11/3/2022 4:38 PM]		 42.68 -2.57 
(-5.68%)		 46.33 1.08 
(2.39%)		 41.10 - 72.11 368,311 160,000 51,879
06-05-2021 AH GLPG Galapagos NV 5,060 -0.24 -1.71 -0.86 Galapagos reports Q1 results
[5/6/2021 4:57 PM]		 75.09 -1.07 
(-1.40%)		 77.30 1.14 
(1.50%)		 73.81 - 233.14 535,001 230,000 9,132
05-11-2020 AH GLPG Galapagos NV 7,870 -1.46 -1.23 8.72 Galapagos EPS misses by $2.64, FY20 guidance
[11/5/2020 4:37 PM]		 119.31 -7.10 
(-5.62%)		 120.56 -5.85 
(-4.63%)		 112.00 - 274.03 163,052 230,738 1,324